Stemgent
The development and commercialization of therapeutics and cellular technologies derived from the placenta.
Launch date
Employees
Market cap
-
Enterprise valuation
$45—68m (Dealroom.co estimates Aug 2012.)
Cambridge Massachusetts (HQ)
Authorizing premium user...